Protein kinase inhibitor - PDFSEARCH.IO - Document Search Engine

Protein kinase inhibitor
Results: 181

#	Item
51	VI. CANCER DE PULMON 1. Genotyping non-small cell lung cancer (NSCLC) in Latin America Arrieta O, Cardona AF, Federico Bramuglia G, Gallo A, Campos-Parra AD, Serrano S, Castro M, Avilés A, Amorin E, Kirchuk R, Cuello M Add to Reading List Source URL: www.inen.sld.pe Language: English - Date: 2014-03-13 18:40:55 KRAS Chemistry Non-small-cell lung carcinoma Protein kinase inhibitor Cetuximab Gefitinib Lung cancer Medicine Oncology
52	Suzanne Hagan PhD Dept of Vision Sciences, Glasgow Caledonian University (GCU), Scotland, UK Employment Lecturer, Department of Vision Science, GCU, Scotland, UK. (Jan 2010-present). Post-doctoral Add to Reading List Source URL: epmanet.eu Language: English - Date: 2012-12-17 17:31:16 Osteonectin C-Raf Uveal melanoma Protein kinase inhibitor Medicine Health Melanoma Carbohydrates Glycoproteins
53	Konstantina Grosios PhD, MPH Biomedical and Health Research Centre (BHRC) & Cancer Research UK Cancer Centre (CR-UK CC) Research Manager University of Leeds, Leeds, UK Add to Reading List Source URL: epmanet.eu Language: English - Date: 2012-12-17 17:31:14 Tyrosine kinase Combretastatin Angiogenesis inhibitor Tyrosine-kinase inhibitor AEE788 Angiogenesis Chemistry Angiology Protein kinase inhibitors Combretastatin A-4 phosphate
54	QSAR based model for discriminating EGFR inhibitors and non-inhibitors using Random forest Add to Reading List Source URL: www.biologydirect.com Language: English Quinazolines Tyrosine kinase receptors Alkynes Organofluorides Epidermal growth factor receptor Erlotinib Gefitinib Fingerprint Protein kinase inhibitor Chemistry Organic chemistry Amines
55	SuperGen PIM Kinase Presentations at AACR DUBLIN, Calif., Mar 31, 2011 (BUSINESS WIRE) -SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today a Add to Reading List Source URL: astx.com Language: English American Association for Cancer Research Protein kinase inhibitor Display board Academia Poster session Serine/threonine-specific protein kinase
56	Encouraging Data on Astex’s Anti-Cancer Drug AT9283 to be Presented at ASH New Data Suggest a Potential Role for AT9283 in Combination With Lenalidomide and With Docetaxel in the Treatment of Multiple Myeloma and Non-H Add to Reading List Source URL: astx.com Language: English Protein kinase inhibitors Tyrosine kinases Immunosuppressants Lenalidomide Orphan drugs CD135 Multiple myeloma Targeted therapy Aurora inhibitor Biology Chemistry Cell biology
57	June 13, 2012 Astex Pharmaceuticals Earns $5.4 Million Milestone on Phase I Trial Initiation of a FGFR Kinase Inhibitor DUBLIN, Calif., June 13, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a phar Add to Reading List Source URL: astx.com Language: English Protein kinase inhibitor Drug discovery Pharmaceutical sciences Pharmacology Astex
58	Astex Pharmaceuticals to Present at AACR Annual Meeting DUBLIN, Calif., March 29, [removed]Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), a pharmaceutical company dedicated to the discovery and development of novel small mole Add to Reading List Source URL: astx.com Language: English Astex Protein kinase inhibitors Drug discovery Aurora inhibitor Pharmaceutical sciences Pharmacology Biology
59	Astex To Present Data From Its FGFR Inhibitor Programme at the American Association for Cancer Research (AACR) 102nd Annual Meeting 2011 Cambridge, UK, 29th March[removed]Astex Therapeutics, the UK-based biotechnology comp Add to Reading List Source URL: astx.com Language: English Pharmacology Clinical research Medicinal chemistry Astex Fibroblast growth factor receptor 1 Fibroblast growth factor receptor Tyrosine kinase Fibroblast growth factor Protein kinase Pharmaceutical sciences Biology Tyrosine kinase receptors
60	AstraZeneca submission to the Post-Market Review of Authority Required PBS listings AstraZeneca welcomes the opportunity to contribute to the Post-Market Review of Authority Required Pharmaceutical Benefits Schedule (PBS Add to Reading List Source URL: pbs.gov.au Language: English - Date: 2015-03-02 18:33:44 Quinazolines Organofluorides Amines Organochlorides Pharmaceutical Benefits Scheme Protein kinase inhibitor Quality use of medicines Gefitinib Erlotinib Chemistry Organic chemistry AstraZeneca